Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 1 Diabetes Mellitus Maturity Onset”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07638345
What this trial is testing

DASH-Obesity: Explainable AI for Family-Centric Personalized Weight Control in Adolescents and Young Adults With Obesity and Chronic Conditions

Who this might be right for
Type 1 DiabetesT1DObesity & Overweight+3 more
Adhera Health, Inc. 280
Testing effectiveness (Phase 2)Study completedNCT00570687
What this trial is testing

A Study Comparing Subcutaneous Rapid Acting Insulin and One Formulation of Inhaled Insulin in Subjects With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Mannkind Corporation 30
Not applicableLooking for participantsNCT07621419
What this trial is testing

Study of Adult Patients Residing in Argentina Diagnosed With Type 2 Diabetes Treated With a New Formulation of Semaglutide, Both Oral and Subcutaneous, in a Real-world Setting at 3 Months, 6 Months, and 1 Year of Follow-up, Quantifying the Reduction in Glycated Hemoglobin

Who this might be right for
Diabetes Mellitus
Hospital Italiano de Buenos Aires 145
Not applicableStudy completedNCT01900834
What this trial is testing

Evaluation of Biomarker Expression in Diabetic and Healthy Subjects Over a One Year Period

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2+1 more
Novo Nordisk A/S 61
Post-approval studies (Phase 4)Study completedNCT00572052
What this trial is testing

Comparison of Glycemic Control Achieved With 2 Different Needles

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2+1 more
Novo Nordisk A/S 62
Post-approval studies (Phase 4)Study completedNCT00569426
What this trial is testing

Evaluating the Use of Two Different Needles in Subjects With Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2+1 more
Novo Nordisk A/S 119
Not applicableStudy completedNCT03081676
What this trial is testing

The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without Sulphonylurea

Who this might be right for
Maturity-Onset Diabetes of the Young, Type 3
University Hospital, Gentofte, Copenhagen 20
Post-approval studies (Phase 4)Study completedNCT04030091
What this trial is testing

Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Sciema UG 24
Not applicableUnknownNCT01745900
What this trial is testing

Evaluation and Comparison of Noninvasive Blood Glucose Concentrations

Who this might be right for
Insulin Dependent DiabetesNon Insulin Dependent DiabetesGestational Diabetes
VeraLight, Inc. 125
Testing effectiveness (Phase 2)WithdrawnNCT04661917
What this trial is testing

A Trial to Learn More About How BAY2327949 Works and How Safe it is in Patients Whose Kidneys Are Damaged Due to High Blood Sugar Levels or High Blood Pressures, and With a Further Disease of the Heart or the Blood Vessels.

Who this might be right for
Chronic Kidney DiseaseDiabetic Kidney Disease
Bayer
Not applicableUnknownNCT02023489
What this trial is testing

Lipid and Glycogen Metabolism in Patients With Impaired Glucose Tolerance and Calcium Sensing Receptor Mutations

Who this might be right for
Type 2 Diabetes MellitusPrediabetes (Insulin Resistance, Impaired Glucose Tolerance)Familiar Hypocalcuric Hypercalcemia+2 more
Medical University of Vienna 90
Early research (Phase 1)Study completedNCT04880291
What this trial is testing

First-In-Human Study of GFB-024 in Healthy Overweight and Obese Participants, and Participants With Type 2 Diabetes

Who this might be right for
Kidney DiseasesDiabetic NephropathiesDiabetes Complications+2 more
Goldfinch Bio, Inc. 39
Large-scale testing (Phase 3)Study completedNCT00773279
What this trial is testing

Efficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in Diabetics

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2+1 more
Novo Nordisk A/S 242
Not applicableUnknownNCT02887625
What this trial is testing

Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DM

Who this might be right for
Type 2 Diabetes
Dr. Muhammad Abdulghani 410
Testing effectiveness (Phase 2)Study completedNCT03514420
What this trial is testing

Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Partial Lipodystrophy (FPL)

Who this might be right for
Familial Partial Lipodystrophy
Akcea Therapeutics 4
Early research (Phase 1)Study completedNCT01433380
What this trial is testing

Evaluate PF-05175157 In Healthy Volunteers

Who this might be right for
Diabetes Mellitus, Type 2
Pfizer 22
Testing effectiveness (Phase 2)Study completedNCT05731544
What this trial is testing

Study of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D)

Who this might be right for
Type 2 Diabetes Mellitus
Biomea Fusion Inc. 443
Not applicableLooking for participantsNCT06203106
What this trial is testing

NYSCF Scientific Discovery Biobank

Who this might be right for
ALSAmyotrophic Lateral SclerosisAlzheimer Disease+26 more
New York Stem Cell Foundation Research Institute 10,000
Large-scale testing (Phase 3)Study completedNCT01733758
What this trial is testing

A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 494
Not applicableStudy completedNCT03259984
What this trial is testing

Epigenetics of Muscle Insulin Resistance

Who this might be right for
Diabetes Mellitus, Type 2Obesity
University of Arizona 72
Next Page